Skip to content

Clinical trials

Phase 2 Stomach Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 2 Country / region: Canada Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20082
20101
20112
20122
20141
20151
20171
20182
20193
20202
20211
20223
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting6
Terminated6
Active, not recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Alliance for Clinical Trials in Oncology2
Bristol-Myers Squibb2
Daiichi Sankyo2
Merck Sharp & Dohme LLC2
National Cancer Institute (NCI)2
Adherex Technologies, Inc.1
Amgen1
Apollomics Inc.1
Arcus Biosciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms31
Esophageal Neoplasms12
Ovarian Neoplasms6
Biliary Tract Neoplasms5
Pancreatic Neoplasms5
Breast Neoplasms4
Colorectal Neoplasms4
Endometrial Neoplasms4
Triple Negative Breast Neoplasms4
Neoplasm Metastasis3

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.